{"id":"Q001","topic":"screening","q":"In a low-risk pregnancy, what is the usual gestational age window for screening gestational diabetes, and what is the typical diagnostic test?","gold_hint":["24–28 weeks","OGTT","75 g","2-hour"],"bad_hint":["postpartum testing","6–12 weeks"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q002","topic":"screening","q":"Why might clinicians test early in pregnancy for hyperglycaemia in women with risk factors, and what does that early testing aim to rule out?","gold_hint":["first trimester","HbA1c or early testing","overt diabetes"],"bad_hint":["routine 24–28 week OGTT only"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q003","topic":"screening","q":"Explain how diagnostic thresholds in OGTT relate to identifying gestational diabetes rather than pre-existing diabetes.","gold_hint":["diagnostic criteria","OGTT thresholds","gestational vs overt diabetes"],"bad_hint":["neonatal complications list only"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q004","topic":"screening","q":"What are common reasons HbA1c is not used as the primary screening test for gestational diabetes later in pregnancy?","gold_hint":["HbA1c not recommended later","screening limitation","pregnancy physiology"],"bad_hint":["HbA1c recommended as primary test"],"expected_relation":"entailment","pair_tests":[{"q":"Is HbA1c recommended for screening gestational diabetes later in pregnancy?","good_answer_hint":["not recommended later in pregnancy"],"bad_answer_hint":["recommended later in pregnancy"],"expect_good":"not_contradiction","expect_bad":"contradiction"}]}
{"id":"Q005","topic":"screening","q":"A clinician suspects GDM but the patient cannot tolerate OGTT. What alternative monitoring approaches are typically discussed and why?","gold_hint":["alternative monitoring","SMBG/CGM","practical considerations"],"bad_hint":["placental hormones mechanism"],"expected_relation":"neutral","pair_tests":[]}
{"id":"Q006","topic":"management","q":"Outline first-line management for gestational diabetes and the main goal of initial therapy before medications are considered.","gold_hint":["lifestyle modification","diet/exercise","glucose targets"],"bad_hint":["OGTT diagnostic thresholds"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q007","topic":"management","q":"If fasting glucose values remain above target despite diet control, what is commonly the next pharmacologic step and why?","gold_hint":["insulin mainstay","fasting values above target","pharmacologic escalation"],"bad_hint":["postpartum follow-up timing"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q008","topic":"management","q":"Describe how self-monitoring of blood glucose is used in gestational diabetes, including what patterns matter clinically.","gold_hint":["SMBG","fasting and postprandial","targets/adjustments"],"bad_hint":["fetal hyperinsulinemia macrosomia"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q009","topic":"management","q":"What is the debate around metformin use in gestational diabetes and what factors influence whether it is used?","gold_hint":["metformin role","benefits/limits","when considered"],"bad_hint":["neonatal respiratory distress only"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q010","topic":"management","q":"Compare CGM vs SMBG in pregnancy diabetes management: what outcomes are typically discussed and what barriers exist?","gold_hint":["CGM vs SMBG","glycemic control","barriers to use"],"bad_hint":["OGTT thresholds detail only"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q011","topic":"pathophysiology","q":"Explain how placental hormones contribute to insulin resistance during pregnancy and when this becomes pathological in GDM.","gold_hint":["placental hormones","insulin resistance","beta-cell compensation","GDM when compensation fails"],"bad_hint":["postpartum OGTT schedule"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q012","topic":"pathophysiology","q":"Why does pregnancy normally increase insulin resistance, and what distinguishes normal adaptation from gestational diabetes?","gold_hint":["physiologic insulin resistance","compensatory insulin secretion","insufficient beta-cell response"],"bad_hint":["birth trauma shoulder dystocia only"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q013","topic":"pathophysiology","q":"Link maternal hyperglycaemia to fetal hyperinsulinaemia using the modified Pedersen hypothesis.","gold_hint":["maternal glucose crosses placenta","fetal insulin production increases","modified Pedersen"],"bad_hint":["metformin dosing details"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q014","topic":"pathophysiology","q":"Give a mechanism chain connecting maternal insulin resistance to macrosomia, emphasizing fetal insulin as a growth factor.","gold_hint":["insulin resistance → hyperglycemia → fetal hyperinsulinemia","growth/adiposity","macrosomia"],"bad_hint":["HbA1c screening later pregnancy recommended"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q015","topic":"pathophysiology","q":"Why can the fetus develop increased fat mass in response to maternal hyperglycaemia even when maternal symptoms are mild?","gold_hint":["glucose transfer","fetal insulin response","adiposity"],"bad_hint":["postpartum surveillance schedule"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q016","topic":"complications","q":"Using fetal insulin physiology, explain why neonatal hypoglycaemia can occur after delivery in pregnancies complicated by hyperglycaemia.","gold_hint":["fetal hyperinsulinemia persists","after birth glucose supply drops","neonatal hypoglycemia"],"bad_hint":["OGTT diagnostic timing"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q017","topic":"complications","q":"What are key neonatal complications associated with diabetes in pregnancy, and what mechanistic theme links many of them?","gold_hint":["neonatal complications list","fetal hyperinsulinemia"],"bad_hint":["adult T2DM risk only"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q018","topic":"complications","q":"Why does macrosomia increase risk of difficult delivery and what delivery complication is commonly discussed?","gold_hint":["macrosomia","difficult delivery","shoulder dystocia/birth trauma"],"bad_hint":["HbA1c early pregnancy only"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q019","topic":"complications","q":"Explain how maternal hyperglycaemia can contribute to polycythaemia and hyperbilirubinaemia in the newborn.","gold_hint":["polycythaemia","hyperbilirubinaemia","neonatal complications"],"bad_hint":["CGM barriers"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q020","topic":"complications","q":"Describe maternal complications associated with GDM and how they relate to insulin resistance and metabolic stress.","gold_hint":["maternal complications","insulin resistance","preeclampsia/metabolic risk"],"bad_hint":["neonatal hypocalcaemia only"],"expected_relation":"entailment","pair_tests":[]}

{"id":"Q021","topic":"postpartum","q":"What postpartum follow-up testing is recommended after gestational diabetes, and in what time window?","gold_hint":["postpartum follow-up","OGTT","6–12 weeks"],"bad_hint":["24–28 week OGTT for diagnosis"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q022","topic":"postpartum","q":"Why is lifelong surveillance recommended after a GDM pregnancy and what long-term risk is commonly cited?","gold_hint":["lifelong surveillance","risk of type 2 diabetes","long-term progression"],"bad_hint":["newborn hypoglycemia mechanism"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q023","topic":"postpartum","q":"Explain the concept that GDM reveals an underlying susceptibility: how does pregnancy act like a metabolic stress test?","gold_hint":["pregnancy as stress test","insulin resistance unmasks beta-cell dysfunction","future T2DM risk"],"bad_hint":["OGTT thresholds only"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q024","topic":"postpartum","q":"What follow-up strategy is suggested for women with prior GDM to reduce future cardiometabolic risk?","gold_hint":["follow-up screening","lifestyle/interventions","cardiometabolic risk reduction"],"bad_hint":["fetal hyperinsulinemia explanation"],"expected_relation":"neutral","pair_tests":[]}
{"id":"Q025","topic":"postpartum","q":"How does postpartum testing differ from prenatal screening, and why can normal postpartum results still warrant ongoing monitoring?","gold_hint":["postpartum testing purpose","risk persists","ongoing monitoring"],"bad_hint":["CGM vs SMBG outcomes only"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q026","topic":"hard_neutral","q":"What is the typical gestational window for GDM screening, and how does it differ from the postpartum testing window? (Answer should focus on BOTH timings.)","gold_hint":["24–28 weeks","postpartum 6–12 weeks","difference"],"bad_hint":["only one timing mentioned"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q027","topic":"hard_neutral","q":"Explain why a normal OGTT during pregnancy does not necessarily rule out future type 2 diabetes risk in someone with GDM history.","gold_hint":["future risk persists","GDM history","surveillance"],"bad_hint":["neonatal complications list"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q028","topic":"hard_neutral","q":"Distinguish between treating maternal glucose targets to prevent fetal complications vs diagnosing GDM to classify risk: what changes clinically?","gold_hint":["treatment targets","prevent fetal outcomes","diagnosis/stratification"],"bad_hint":["HbA1c alone"],"expected_relation":"neutral","pair_tests":[]}
{"id":"Q029","topic":"hard_neutral","q":"A question mentions OGTT, HbA1c, and postpartum follow-up in one paragraph. Identify what belongs to diagnosis vs what belongs to surveillance.","gold_hint":["diagnosis: OGTT 24–28","early HbA1c risk","surveillance postpartum OGTT"],"bad_hint":["everything treated as same test purpose"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q030","topic":"hard_neutral","q":"A summary claims: 'HbA1c is the main screening test for GDM late pregnancy.' What is the most likely relationship label and why?","gold_hint":["not recommended","contradiction signal"],"bad_hint":["supports claim"],"expected_relation":"contradiction","pair_tests":[]}
{"id":"Q031","topic":"pathophysiology","q":"Describe the transition from insulin resistance to overt diabetes using pregnancy physiology: what fails first?","gold_hint":["insulin resistance rises","beta-cell compensation fails","overt hyperglycaemia"],"bad_hint":["neonatal jaundice only"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q032","topic":"pathophysiology","q":"In mechanistic terms, why is fetal insulin considered central in the pathway from maternal hyperglycaemia to increased fetal size?","gold_hint":["fetal insulin growth factor","glucose transfer","fat mass"],"bad_hint":["metformin adverse effects only"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q033","topic":"complications","q":"Explain how maternal hyperglycaemia can lead to both macrosomia and neonatal respiratory issues, via downstream metabolic effects.","gold_hint":["macrosomia pathway","neonatal complications","respiratory issues mentioned"],"bad_hint":["postpartum testing schedule"],"expected_relation":"neutral","pair_tests":[]}
{"id":"Q034","topic":"management","q":"What triggers escalation from lifestyle to pharmacologic therapy in GDM, and what is the mainstay medication typically stated?","gold_hint":["persistent elevated glucose","targets not met","insulin mainstay"],"bad_hint":["OGTT used postpartum"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q035","topic":"screening","q":"A clinician asks: 'Why screen at 24–28 weeks rather than earlier for everyone?' Provide the physiological rationale.","gold_hint":["insulin resistance increases later pregnancy","placental hormones","screening window"],"bad_hint":["neonatal hypocalcaemia"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q036","topic":"postpartum","q":"What is the rationale for postpartum OGTT rather than relying only on fasting glucose, and how does this relate to later T2DM risk?","gold_hint":["postpartum OGTT rationale","detect dysglycaemia","later T2DM risk"],"bad_hint":["CGM decreases HbA1c"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q037","topic":"complications","q":"Why can a newborn experience hypoglycaemia soon after delivery if maternal glucose was high during pregnancy? Provide the physiological explanation.","gold_hint":["fetal insulin high","glucose supply drops after birth"],"bad_hint":["screening window 24–28"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q038","topic":"management","q":"How do glucose monitoring patterns (fasting vs postprandial) influence therapy adjustment in GDM?","gold_hint":["fasting vs postprandial targets","therapy adjustments"],"bad_hint":["placental lactogen only"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q039","topic":"screening","q":"What distinguishes diagnosing hyperglycaemia in early pregnancy from diagnosing GDM at 24–28 weeks in clinical guidelines?","gold_hint":["early pregnancy detects overt diabetes","later OGTT diagnoses GDM"],"bad_hint":["insulin therapy mainstay"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q040","topic":"postpartum","q":"Explain how GDM increases long-term maternal cardiometabolic risk even if pregnancy glucose normalizes after delivery.","gold_hint":["underlying metabolic susceptibility","future risk","surveillance"],"bad_hint":["neonatal polycythaemia"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q041","topic":"hard_neutral","q":"This question blends management and complications: 'How does controlling maternal glucose reduce macrosomia risk, and what is first-line management to achieve that control?'","gold_hint":["control maternal glucose reduces fetal hyperinsulinemia/macrosomia","lifestyle first-line"],"bad_hint":["OGTT threshold tables"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q042","topic":"hard_neutral","q":"Explain why a claim about postpartum OGTT timing is NOT an answer to a question about diagnostic OGTT thresholds in pregnancy.","gold_hint":["different purpose: surveillance vs diagnosis"],"bad_hint":["treat as same"],"expected_relation":"neutral","pair_tests":[]}
{"id":"Q043","topic":"hard_neutral","q":"A paragraph says: 'GDM causes neonatal hypoglycaemia.' Is that fully accurate without the fetal insulin step? What evidence should be present?","gold_hint":["fetal hyperinsulinemia mediates neonatal hypoglycemia"],"bad_hint":["skip fetal insulin step"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q044","topic":"pathophysiology","q":"Explain the compensatory beta-cell response in pregnancy and why inadequate compensation leads to GDM.","gold_hint":["beta-cell compensation","insulin secretion increases","fails → GDM"],"bad_hint":["shoulder dystocia"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q045","topic":"complications","q":"List several neonatal complications linked to diabetes in pregnancy and identify the unifying endocrine driver.","gold_hint":["neonatal complications","fetal hyperinsulinemia"],"bad_hint":["metformin role"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q046","topic":"screening","q":"Why is the 24–28 week window considered a sweet spot for detecting pregnancy-related glucose intolerance?","gold_hint":["insulin resistance peaks later","placental hormones"],"bad_hint":["postpartum surveillance only"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q047","topic":"management","q":"A patient refuses insulin and asks about oral options. How should metformin be framed in GDM discussions, including limitations?","gold_hint":["metformin role","limitations/considerations"],"bad_hint":["fetal polycythaemia"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q048","topic":"postpartum","q":"Why does prior GDM warrant ongoing screening even after a normal postpartum test, and what long-term outcome is being prevented?","gold_hint":["ongoing screening","prevent/detect T2DM","risk persists"],"bad_hint":["OGTT for diagnosis at 24–28 only"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q049","topic":"complications","q":"Explain how uncontrolled maternal glucose can lead to increased fetal fat mass and difficult delivery outcomes.","gold_hint":["maternal glucose crosses placenta","fetal insulin","fat mass/macrosomia","difficult delivery"],"bad_hint":["HbA1c recommended late pregnancy"],"expected_relation":"entailment","pair_tests":[]}
{"id":"Q050","topic":"hard_neutral","q":"A clinician asks for a single chain: 'placental hormones → insulin resistance → maternal hyperglycaemia → fetal insulin → macrosomia'. Provide the minimal evidence steps that must appear.","gold_hint":["all chain steps present","no skipped causal link"],"bad_hint":["only mentions macrosomia and hyperglycaemia without fetal insulin"],"expected_relation":"entailment","pair_tests":[]}
